The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease-Reference-Cited by-同舟云学术

The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease

Published:2018-04 Issue: Volume:49 Page:42-47
ISSN:1353-8020
Container-title:Parkinsonism & Related Disorders
language:en
Short-container-title:Parkinsonism & Related Disorders

Author:

Zielonka Daniel,Ren Michał,De Michele Giuseppe,Roos Raymund A.C.,Squitieri Ferdinando,Bentivoglio Anna Rita,Marcinkowski Jerzy T.,Landwehrmeyer G. Bernhard

Publisher

Elsevier BV

Subject

Clinical Neurology,Geriatrics and Gerontology,Neurology

Reference27 articles.

1. Update on Huntington's disease: advances in care and emerging therapeutic options;Zielonka;Park. Relat. Disord.,2015

2. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease;Snell;Nat. Genet.,1993

3. The influence of gender on phenotype and disease progression in patients with Huntington's disease;Zielonka;Park. Relat. Disord.,2013

4. Cognitive and psychiatric aspects of Huntington disease contribute to functional capacity;Nehl;J. Nerv. Ment. Dis.,2004

5. Determinants of functional disability in Huntington's disease: role of cognitive and motor dysfunction;Ross;Mov. Disord.,2014

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathomechanisms of behavioral abnormalities in Huntington disease: an update;Journal of Neural Transmission;2024-06-14

2. Sex differences in Huntington's disease from a neuroinflammation perspective;Frontiers in Neurology;2024-06-10

3. Sex-Specific Differences in the Progression of Huntington's Disease Symptoms: A National Study in China;Neuroepidemiology;2024-05-30

4. Genetic mouse models to explore Huntington's disease mechanisms and therapeutic strategies;Huntington's Disease;2024

5. Activin A targets extrasynaptic NMDA receptors to improve neuronal and behavioral deficits in a mouse model of Huntington disease;2023-09-06